SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
I noticed Alexion when both Salomon and Robertson Stephens issued "strong buys" several weeks ago. In reviewing their portfolio, it appears that they are targeting the following areas: (a) Xenotransplantation, with U.S. Surgical as a partner, and with U.S. Surgical recently purchasing $3 million in ALXN at $17.97 (b) Cardiopulmonary disease, utilizing C5 Complement Inhibitors, with a succesful Phase I/II completed for cardiopulmonary bypass, and with pre-clinical work for myocardial infarction, and (c) Autoimmune disease, with what they refer to as Apogen T-Cell Therapeutics, with the intent to initially file an IND in '97 for MS, following strong pre-clinical data. With the conversion to stock from private placements, there are probabaly some 9 million shares outstanding. I am researching the company and am interested if anyone has an informed opinion as to the prospects for this company.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
824>> Highly irrelevant << Want to go back and point out that I was arscaram(o)uche-1/15/2014
823Two papers from the NEJM (thanks to David Miller who doesn't like the journaidos-1/29/2009
822Alexion: Blood disorder drug does well in Japan Monday December 8, 4:24 pm ET Altnsaf-12/8/2008
821Alexion scientist has an affinity for Oklahoma Executive Q&A with Russell RoIcebrg-11/2/2008
820Alexion Reports Third Quarter 2008 Results Thursday October 23, 6:30 am ET CoDoc Bones-10/23/2008
819Alexion Q3 profit beats Street, raises 2008 rev view Thu Oct 23, 2008 8:57am EDDoc Bones-10/23/2008
818National reimbursement decision being made by top department in UK. Decision prkenhott-9/24/2008
817Speculating on Alexion Pharma Posted By:Tom Brennan Viewers should know by now Icebrg-8/15/2008
816Why are Investors so Pessimistic on Uptrending Alexion Pharmaceuticals? ExaminiIcebrg-6/28/2008
815Item 8.01 Other Events. As previously reported by Alexion Pharmaceuticals, Inc.Icebrg-6/3/2008
814$1B for 2-3 K pts? Good Lord, we on Earth are very lucky to have only 6.6 B popMiljenko Zuanic-5/30/2008
813Alexion rated 'Buy' as analyst says Soliris revenue could surpass $1 bilIcebrg-5/30/2008
812Drug industry is expanding in Rhode Island 01:00 AM EDT on Tuesday, May 27, 2008Icebrg-5/28/2008
811C5 Blockade with Conventional Immunosuppression Induces Long-Term Graft SurvivalIcebrg-5/2/2008
810Anaphore was created through the acquisition of Borean Pharma ApS, a Danish biotIcebrg-4/16/2008
809Nice action in ALXN today relative to other bios. JonRobohogs-2/21/2008
808Alexion called a potential bounce play by Shark Biotech: notablecalls.blogspot.tuck-2/21/2008
807Alexion Pharmaceuticals "buy," target price raised 02/18/08 - UBS NEWIcebrg-2/19/2008
806Wachovia Downgrades Alexion Pharma Associated Press 02.15.08, 6:25 PM ET AlexioIcebrg-2/19/2008
805hal.inserm.fr hal.inserm.fr CD200: a putative therapeutic target in cancer. autkenhott-2/5/2008
804Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 2kenhott-2/5/2008
803scibx.com --------------------------- Press Release Source: BioCentury BioCentkenhott-2/5/2008
802Form 8-K for ALEXION PHARMACEUTICALS INC 4-Feb-2008 Other Events Item 8.01 Otkenhott-2/4/2008
801Saw this while looking into some GBS stuff. It seems that Soliris may stop GuilIan@SI-2/1/2008
800Press Release Source: Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals to kenhott-12/7/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News